Coldrif Syrup manufactured in May 2025 by Sresan Pharmaceutical Manufacturer, Tamil Nadu, was found to be adulterated (Image: PTI) Show Quick Read Summary is AI Generated. Newsroom Reviewed

The Delhi government has banned the sale, purchase, and distribution of the toxic Coldrif cough syrup, joining a growing list of states taking emergency action after the medicine, linked to the deaths of at least 22 children in Madhya Pradesh, was found to contain poisonous industrial solvent at dangerously high levels. The ban follows an official order declaring the syrup 'not of standard quality' due to dangerous contamination.

The product, specifically Coldrif Syrup manufactured in May 2025 by Sresan Pharmaceutical Manufacturer, Tamil Nadu, was found to be adulterated with Diethylene Glycol (D

See Full Page